Biogen Inc (BIIB)
157.90
-0.11
(-0.07%)
USD |
NASDAQ |
Nov 22, 16:00
158.00
+0.10
(+0.06%)
After-Hours: 20:00
Biogen Free Cash Flow (Quarterly): 805.60M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 805.60M |
| June 30, 2024 | 583.20M |
| March 31, 2024 | 432.30M |
| December 31, 2023 | -52.70M |
| September 30, 2023 | 504.80M |
| June 30, 2023 | 400.00M |
| March 31, 2023 | 383.70M |
| December 31, 2022 | -262.40M |
| September 30, 2022 | 601.90M |
| June 30, 2022 | 697.70M |
| March 31, 2022 | 103.90M |
| December 31, 2021 | 769.80M |
| September 30, 2021 | 743.40M |
| June 30, 2021 | 1.155B |
| March 31, 2021 | 676.40M |
| December 31, 2020 | -468.10M |
| September 30, 2020 | 1.097B |
| June 30, 2020 | 1.844B |
| March 31, 2020 | 1.206B |
| December 31, 2019 | 1.695B |
| September 30, 2019 | 1.605B |
| June 30, 2019 | 1.777B |
| March 31, 2019 | 1.332B |
| December 31, 2018 | 1.670B |
| September 30, 2018 | 1.545B |
| Date | Value |
|---|---|
| June 30, 2018 | 834.50M |
| March 31, 2018 | 1.252B |
| December 31, 2017 | 1.223B |
| September 30, 2017 | 1.349B |
| June 30, 2017 | 846.40M |
| March 31, 2017 | -830.00M |
| December 31, 2016 | 1.399B |
| September 30, 2016 | 710.60M |
| June 30, 2016 | 890.00M |
| March 31, 2016 | 860.30M |
| December 31, 2015 | 1.048B |
| September 30, 2015 | 659.90M |
| June 30, 2015 | 917.40M |
| March 31, 2015 | 635.20M |
| December 31, 2014 | 797.70M |
| September 30, 2014 | 851.49M |
| June 30, 2014 | 926.59M |
| March 31, 2014 | 50.32M |
| December 31, 2013 | 790.37M |
| September 30, 2013 | 591.73M |
| June 30, 2013 | -2.692B |
| March 31, 2013 | 145.65M |
| December 31, 2012 | 438.87M |
| September 30, 2012 | 483.72M |
| June 30, 2012 | 562.68M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-468.10M
Minimum
Dec 2020
1.844B
Maximum
Jun 2020
645.79M
Average
639.15M
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly and Co | -458.90M |
| Pfizer Inc | 6.063B |
| Sage Therapeutics Inc | -82.36M |
| Amgen Inc | 3.314B |
| Ionis Pharmaceuticals Inc | -111.30M |